With regulatory approval secured, OPG's Darlington reactors will become single largest source of isotope production in North America
TORONTO, May 28, 2025 /CNW/ - Cancer patients around the world could soon benefit from improved access to potentially life-saving treatments generated by the production of two critical medical isotopes – Yttrium-90 (Y-90) and Lutetium-177 (Lu-177) – at Ontario Power Generation's (OPG) Darlington Nuclear Generating Station.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/NVIDIA%20Corp%20logo%20on%20phone-by%20Evolf%20via%20Shutterstock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/Semiconductor%20chip%20by%20Mykola%20Pokhodzhay%20via%20iStock.jpg)